CapitolRadar

GMED

CapitolRadar tracks every publicly disclosed GMED trade by US congress members and corporate insiders: 10 disclosed trades (4 buys, 6 sells) by 3 tracked traders, from 2020-05-28 to 2026-08-19. Updated daily from official filings.

Disclosed trades10
Tracked buyers3
Last disclosed trade2026-08-19
Price$75.49

Want a ping when Congress buys GMED? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free

Globus Medical, Inc. (GMED) — Healthcare · Medical - Devices, market cap about $10.1B.

CapitolRadar analysis

10 tracked GMED trades split 4 buys to 6 sells

GMED has 10 tracked trades from May 28, 2020 through August 19, 2026: 4 buys and 6 sells involving 3 distinct traders. The activity spans seven reported quarters, but the sample remains small. Three trades occurred in 2022 Q2, the busiest quarter in the dataset, including 2 buys. The next-highest count was 2 trades in 2023 Q1, both sells.

The other five represented quarters each contain a single trade. Those records were a sell in 2020 Q2, a sell in 2022 Q3, a buy in 2023 Q2, a sell in 2025 Q2, and a buy in 2026 Q3. Overall, sells exceed buys by 2 transactions, although the limited number of observations makes broad conclusions about direction or consistency difficult.

3 disclosed buyers account for all 4 purchases

Ro Khanna recorded 2 GMED buys, the most among the listed buyers, with the latest dated May 23, 2022. Josh Gottheimer recorded 1 buy dated April 3, 2023. Gilbert Cisneros recorded 1 buy dated August 19, 2026. Together, these three traders account for all 4 tracked GMED purchases. The supplied data does not provide transaction amounts, prices, or the identities associated with the 6 sells.

6 other tickers overlap across pairs of GMED buyers

Two of the three GMED buyers also bought each of PWR, PODD, PLTR, ACN, GS, and ETN. These overlaps show shared ticker exposure among pairs of buyers, but the small three-buyer sample does not establish a broader trading pattern, common timing, or similar position sizes.

Congressional transaction disclosures can be filed up to 45 days after a trade, so reported activity may not be timely. Disclosed transaction amounts are generally presented as ranges, making amount-based values estimates rather than exact figures; no amount ranges are included in the supplied GMED data.

Analysis written from the tracked record on 2026-09-13; it is refreshed whenever the underlying numbers change.

Activity by quarter

QuarterDisclosed tradesBuysSells
2026 Q3110
2025 Q2101
2023 Q2110
2023 Q1202
2022 Q3101
2022 Q2321
2020 Q2101

Who is buying GMED?

TraderDisclosed buysLast buyGrade
Ro Khanna22022-05-23—
Gilbert Cisneros12026-08-19—
Josh Gottheimer12023-04-03—

Disclosed trades in GMED

DateWhoTypeAmount30d vs SPY
2026-08-19Gilbert Cisnerosbuy$15,001 - $50,000—
2025-04-09Josh Gottheimersell$1,001 - $15,000—
2023-04-03Josh Gottheimerbuy$1,001 - $15,000—
2023-02-08Josh Gottheimersell$1,001 - $15,000—
2023-01-11Josh Gottheimersell$1,001 - $15,000—
2022-08-23Ro Khannasell$1,001 - $15,000—
2022-06-27Ro Khannasell$1,001 - $15,000—
2022-05-23Ro Khannabuy$1,001 - $15,000—
2022-05-10Ro Khannabuy$1,001 - $15,000—
2020-05-28Josh Gottheimersell$1,001 - $15,000—

These buyers also bought

Other stocks the tracked buyers of GMED disclosed buying in the last six months: AMD (3) · MSFT (3) · ETN (2) · RSG (2) · FCX (2) · NVDA (2).

About Globus Medical, Inc.

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation te…

Frequently asked questions

Which politicians bought GMED most?

Ro Khanna leads with 2 disclosed buys, followed by Gilbert Cisneros.

How current is this page?

It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.

Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.

Join CapitolRadar free

CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.